![Richard Slansky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 22 811 $ in data 31/05/2026
Richard B. Slansky currently works at Genenta Science SpA, as Chief Financial Officer from 2021 and CN Biosciences, Inc., as Chief Financial Officer.
Mr. Slansky also formerly worked at Quick Strike Resources, Inc., as Director, Chief Executive & Financial Officer from 2002 to 2003, Path 1 Network Technologies, Inc., as CFO, Secretary, VP-Administration & Operations from 2000 to 2002, SpaceDev, Inc., as President, Chief Financial Officer & Secretary, Star Equity Holdings, Inc., as Chief Financial Officer & Head-Investor Relations from 2010 to 2012, OncoSec Medical, Inc., as CFO, Secretary & Principal Accounting Officer, GenMark Diagnostics, Inc., as Chief Financial Officer from 2012 to 2014, and Biological Dynamics, Inc., as Chief Financial Officer.
Mr. Slansky received his Masters Business Admin degree from the University of Arizona and undergraduate degree from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GENENTA SCIENCE SPA 0,12% | 30/03/2026 | 22.147 ( 0,12% ) | 22 811 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Direttore Finanziario/CFO | 20/05/2021 |
CN Biosciences, Inc.
 CN Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops products used worldwide in disease-related life sciences research | Direttore Finanziario/CFO | - |
| Società | Posizione | Fine |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Direttore Finanziario/CFO | 16/07/2018 |
| GENMARK DIAGNOSTICS, INC. | Direttore Finanziario/CFO | 13/05/2014 |
| STAR EQUITY HOLDINGS | Direttore Finanziario/CFO | 20/04/2012 |
SpaceDev, Inc.
 SpaceDev, Inc. Aerospace & DefenseElectronic Technology Develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles | Direttore Finanziario/CFO | - |
Quick Strike Resources, Inc. | Presidente | 01/02/2003 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
CN Biosciences, Inc.
CN Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops products used worldwide in disease-related life sciences research | Health Technology |
Path 1 Network Technologies, Inc.
 Path 1 Network Technologies, Inc. Internet Software/ServicesTechnology Services Offers internet protocol video transport products | Technology Services |
SpaceDev, Inc.
SpaceDev, Inc. Aerospace & DefenseElectronic Technology Develops spacecraft microsats, nanosats and maneuvering and orbital transfer vehicles | Electronic Technology |
Star Operating Cos., Inc.
 Star Operating Cos., Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures diagnostic imaging solutions, gamma cameras and construction | Health Technology |
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes immunoassays, serology, molecular & tissue diagnostic testing systems | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quick Strike Resources, Inc. | |
Biological Dynamics, Inc.
 Biological Dynamics, Inc. Medical DistributorsDistribution Services Designs and develops cancer screening equipment | Distribution Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
